News - AstraZeneca, Hutchison MediTech

Filter

Popular Filters

Positive outlook for Hutchison China MediTech, say analysts

21-01-2013

Analysts at Panmure Gordon & Co say they remain buyers of Hutchison China MediTech (LSE: HCM), which…

AstraZenecaFinancialHutchison MediTechLicensingPharmaceuticalvolitinib

Back to top